Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1080/1120009X.2024.2330835
dc.identifier.other
WOS:001187079800001
dc.description.volume
dc.description.issue
Publisher
TAYLOR \& FRANCIS LTD
DOI
10.1080/1120009X.2024.2330835